Pulmonx
LUNG
LUNG
104 hedge funds and large institutions have $574M invested in Pulmonx in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 30 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 20
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
78% less call options, than puts
Call options by funds: $210K | Put options by funds: $949K
Holders
104
Holding in Top 10
2
Calls
$210K
Puts
$949K
Top Buyers
| 1 | +$11.2M | |
| 2 | +$5.11M | |
| 3 | +$4.25M | |
| 4 |
Goldman Sachs
New York
|
+$3.89M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$3.33M |
Top Sellers
| 1 | -$9.13M | |
| 2 | -$4.94M | |
| 3 | -$4.93M | |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$4.67M |
| 5 |
Morgan Stanley
New York
|
-$4.56M |